Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial

Clinical trial NCT07732218 · COMPLETED

Trial details

NCT number: NCT07732218
Sponsor: Rehman Medical Institute - RMI
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2022-07-04
Primary completion: 2023-03-30
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.